-
1by Brown, David M Nguyen, Quan Dong Marcus, Dennis M Boyer, David S Patel, Sunil Feiner, Leonard Schlottmann, Patricio G Rundle, Amy Chen Zhang, Jiameng Rubio, Roman G Adamis, Anthony P Ehrlich, Jason S Hopkins, J Jill Published in Ophthalmology (Rochester, Minn.) (01.10.2013)“...To report 36-month outcomes of RIDE (NCT00473382) and RISE (NCT00473330), trials of ranibizumab in diabetic macular edema (DME). Phase III, randomized,...”
-
2by Nguyen, Quan Dong Brown, David M Marcus, Dennis M Boyer, David S Patel, Sunil Feiner, Leonard Gibson, Andrea Sy, Judy Rundle, Amy Chen Hopkins, J Jill Rubio, Roman G Ehrlich, Jason S Published in Ophthalmology (Rochester, Minn.) (01.04.2012)“...To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic macular edema (DME) patients. Two parallel, methodologically identical, phase III,...”
-
3by Boyer, David S., MD Yoon, Young Hee, MD, PhD Belfort, Rubens, MD, PhD Bandello, Francesco, MD Maturi, Raj K., MD Augustin, Albert J., MD Li, Xiao-Yan, MD Cui, Harry, MS Hashad, Yehia, MD Whitcup, Scott M., MD Published in Ophthalmology (Rochester, Minn.) (2014)“...Purpose To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with...”
-
4by Das, Arup, MD, PhD McGuire, Paul G., PhD Rangasamy, Sampathkumar, PhD Published in Ophthalmology (Rochester, Minn.) (2015)“...Diabetic macular edema (DME) is the major cause of vision loss in diabetic persons. Alteration of the blood–retinal barrier is the hallmark of this disease,...”
-
5by Wells, John A Glassman, Adam R Ayala, Allison R Jampol, Lee M Bressler, Neil M Bressler, Susan B Brucker, Alexander J Ferris, Frederick L Hampton, G Robert Jhaveri, Chirag Melia, Michele Beck, Roy W Published in Ophthalmology (Rochester, Minn.) (01.06.2016)“...To provide 2-year results comparing anti-vascular endothelial growth factor (VEGF) agents for center-involved diabetic macular edema (DME) using a standardized...”
-
6by Korobelnik, Jean-François, MD Do, Diana V., MD Schmidt-Erfurth, Ursula, MD Boyer, David S., MD Holz, Frank G., MD Heier, Jeffrey S., MD Midena, Edoardo, MD Kaiser, Peter K., MD Terasaki, Hiroko, MD Marcus, Dennis M., MD Nguyen, Quan D., MD Jaffe, Glenn J., MD Slakter, Jason S., MD Simader, Christian, MD Soo, Yuhwen, PhD Schmelter, Thomas, PhD Yancopoulos, George D., MD, PhD Stahl, Neil, PhD Vitti, Robert, MD Berliner, Alyson J., MD, PhD Zeitz, Oliver, MD Metzig, Carola, MD Brown, David M., MD Published in Ophthalmology (Rochester, Minn.) (2014)“...Purpose A head-to-head comparison was performed between vascular endothelial growth factor blockade and laser for treatment of diabetic macular edema (DME)...”
-
7by Wells, John A Glassman, Adam R Ayala, Allison R Jampol, Lee M Aiello, Lloyd Paul Antoszyk, Andrew N Arnold-Bush, Bambi Baker, Carl W Bressler, Neil M Browning, David J Elman, Michael J Ferris, Frederick L Friedman, Scott M Melia, Michele Pieramici, Dante J Sun, Jennifer K Beck, Roy W Published in The New England journal of medicine (26.03.2015)“...A trial of three drugs — bevacizumab, ranibizumab, and aflibercept — for the treatment of diabetic macular edema showed that each drug improved visual acuity,...”
-
8by Elman, Michael J., MD Ayala, Allison, MS Bressler, Neil M., MD Browning, David, MD Flaxel, Christina J., MD Glassman, Adam R., MS Jampol, Lee M., MD Stone, Thomas W., MD Published in Ophthalmology (Rochester, Minn.) (2015)“...Objective To report 5-year results from a previously reported trial evaluating intravitreal 0.5 mg ranibizumab with prompt versus deferred (for ≥24 weeks)...”
-
9by Brown, David M Schmidt-Erfurth, Ursula Do, Diana V Holz, Frank G Boyer, David S Midena, Edoardo Heier, Jeffrey S Terasaki, Hiroko Kaiser, Peter K Marcus, Dennis M Nguyen, Quan D Jaffe, Glenn J Slakter, Jason S Simader, Christian Soo, Yuhwen Schmelter, Thomas Yancopoulos, George D Stahl, Neil Vitti, Robert Berliner, Alyson J Zeitz, Oliver Metzig, Carola Korobelnik, Jean-François Published in Ophthalmology (Rochester, Minn.) (01.10.2015)“...To compare efficacy and safety of 2 dosing regimens of intravitreal aflibercept injection (IAI) with macular laser photocoagulation for diabetic macular edema...”
-
10by HALLER, Julia A BANDELLO, Francesco WHITCUP, Scott M BELFORT, Rubens BLUMENKRANZ, Mark S GILLIES, Mark HEIER, Jeffrey LOEWENSTEIN, Anat YOUNG HEE YOON JIAO, Jenny LI, Xiao-Yan Published in Ophthalmology (Rochester, Minn.) (2011)“...To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal implant (DEX implant) over 12 months in eyes with macular edema owing...”
-
11by CAMPOCHIARO, Peter A HEIER, Jeffrey S FEINER, Leonard GRAY, Sarah SAROJ, Namrata RUNDLE, Amy Chen YEE MURAHASHI, Wendy RUBIO, Roman G Published in Ophthalmology (Rochester, Minn.) (2010)“...To assess efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular edema following branch retinal vein occlusion...”
-
12by Schmidt-Erfurth, Ursula Lang, Gabriele E Holz, Frank G Schlingemann, Reinier O Lanzetta, Paolo Massin, Pascale Gerstner, Ortrud Bouazza, Abdelkader Si Shen, Haige Osborne, Aaron Mitchell, Paul Published in Ophthalmology (Rochester, Minn.) (2014)“...To evaluate long-term efficacy and safety profiles during 3 years of individualized ranibizumab treatment in patients with visual impairment due to diabetic...”
-
13by Campochiaro, Peter A., MD Brown, David M., MD, FACS Awh, Carl C., MD Lee, S. Young, MD Gray, Sarah, PhD Saroj, Namrata, OD Murahashi, Wendy Yee, MD Rubio, Roman G., MD Published in Ophthalmology (Rochester, Minn.) (2011)“...Purpose Assess the 12-month efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular edema after central retinal...”
-
14by HEIER, Jeffrey S CAMPOCHIARO, Peter A YAU, Linda ZHENGRONG LI SAROJ, Namrata RUBIO, Roman G LAI, Phillip Published in Ophthalmology (Rochester, Minn.) (2012)“...To assess long-term safety and efficacy of intraocular ranibizumab injections in patients with macular edema after retinal vein occlusion (RVO). Open-label...”
-
15by BROWN, David M CAMPOCHIARO, Peter A SINGH, Rishi P ZHENGRONG LI GRAY, Sarah SAROJ, Namrata RUNDLE, Amy Chen RUBIO, Roman G YEE MURAHASHI, Wendy Published in Ophthalmology (Rochester, Minn.) (2010)“...To assess the efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular edema after central retinal vein occlusion...”
-
16by Gillies, Mark C Lim, Lyndell L Campain, Anna Quin, Godfrey J Salem, Wedad Li, Ji Goodwin, Stephanie Aroney, Christine McAllister, Ian L Fraser-Bell, Samantha Published in Ophthalmology (Rochester, Minn.) (01.12.2014)“...To report the 12-month results of the first head-to-head comparison of a dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, CA) versus bevacizumab...”
-
17by Gonzalez, Victor H Campbell, Joanna Holekamp, Nancy M Kiss, Szilárd Loewenstein, Anat Augustin, Albert J Ma, Julia Ho, Allen C Patel, Vaishali Whitcup, Scott M Dugel, Pravin U Published in American journal of ophthalmology (2016)“...Abstract Purpose To determine whether early visual acuity response to ranibizumab in diabetic macular edema is associated with long-term outcome. Design...”
-
18by Sahni, Jayashree Patel, Sunil S Dugel, Pravin U Khanani, Arshad M Jhaveri, Chirag D Wykoff, Charles C Hershberger, Vrinda S Pauly-Evers, Meike Sadikhov, Shamil Szczesny, Piotr Schwab, Dietmar Nogoceke, Everson Osborne, Aaron Weikert, Robert Fauser, Sascha Published in Ophthalmology (Rochester, Minn.) (01.08.2019)“...The phase 2 BOULEVARD trial compared safety and efficacy of faricimab, a novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth...”
-
19by Braithwaite, Tasanee Nanji, Afshan A Lindsley, Kristina Greenberg, Paul B Braithwaite, Tasanee Published in Cochrane library (01.05.2014)“...Background Central retinal vein occlusion (CRVO) is a relatively common retinal vascular disorder in which macular oedema may develop, with a consequent...”
-
20by Freund, K Bailey Korobelnik, Jean-François Devenyi, Robert Framme, Carsten Galic, John Herbert, Edward Hoerauf, Hans Lanzetta, Paolo Michels, Stephan Mitchell, Paul Monés, Jordi Regillo, Carl Tadayoni, Ramin Talks, James Wolf, Sebastian Published in Retina (Philadelphia, Pa.) (01.08.2015)“...A review of treat-and-extend regimens (TERs) with intravitreal anti-vascular endothelial growth factor agents in retinal diseases. There is a lack of consensus...”